Cannabis and Opioid Substitution
Cannabis shows weak evidence for opioid-sparing in chronic pain; no established role in addiction treatment.
This article is for information only and is not medical advice. Talk to a doctor before using cannabis for a health condition, and do not stop or change prescribed treatment on your own.
Cannabis can plausibly reduce opioid doses in some chronic pain patients—the evidence is weak but not zero. However, it is not a treatment for opioid addiction itself. The famous claim that medical cannabis laws reduce overdose deaths was reversed when researchers analysed longer time periods. If you have opioid addiction, buprenorphine or methadone are life-saving and evidence-based. Cannabis might help alongside them, but not instead of them.
Plain-language summary
This is not medical advice. Talk to a clinician before changing opioid medication. Stopping opioids abruptly can cause serious withdrawal and increases overdose risk if you relapse.
The core question—can cannabis help people take fewer opioids, or quit them entirely?—splits into three separate questions with very different answers.
- In chronic pain patients already on opioids, some observational studies and patient surveys suggest cannabis can reduce opioid doses Weak / limited. Randomized trial evidence is limited and mixed [1][2].
- As a treatment for opioid use disorder (OUD) — the addiction itself — cannabis is not an established treatment. Buprenorphine, methadone, and naltrexone are Strong evidence[3].
- At the population level, an influential 2014 study found medical cannabis laws correlated with lower opioid overdose death rates [4]. A 2019 reanalysis extending the data to 2017 found the opposite [5] Disputed.
The bottom line: cannabis is not a substitute for proven addiction treatment, though it may help some people reduce opioid doses for chronic pain.
What probably works
Medications for opioid use disorder (MOUD) — not cannabis — remain the gold standard. Buprenorphine and methadone substantially reduce overdose death, illicit opioid use, and all-cause mortality in people with OUD Strong evidence[3][6]. Any serious discussion of cannabis and opioids must begin here: if someone has OUD, the evidence-based, life-saving treatment is MOUD.
Cannabinoids reduce pain severity modestly. Whole-plant cannabis, nabiximols (Sativex), and synthetic THC produce measurable reductions in chronic pain scores in randomized controlled trials Strong evidence[1]. The effect size is small to moderate—comparable to other adjunctive treatments but not transformative—and variation across trials is substantial.
What might work
Opioid-sparing in chronic pain patients. Observational studies and patient-reported outcomes consistently find that people using medical cannabis report reducing their opioid use, sometimes substantially [2] Weak / limited. A 2017 Minnesota Department of Health review of patients enrolled in the state's intractable pain program found approximately 38% of those taking opioids at baseline had reduced or eliminated them after six months on medical cannabis. Self-report bias, selection effects, and lack of blinding are significant limitations; controlled trials are lacking.
CBD for opioid craving and anxiety. A 2019 double-blind randomized trial by Hurd and colleagues found cannabidiol reduced cue-induced craving and anxiety in 42 people with heroin use disorder [7] Weak / limited. This is promising but represents one study with short follow-up and no hard endpoints (relapse or overdose). Replication in larger trials is needed.
Cannabis as an adjunct during opioid tapering. Some clinical pain and addiction programs report anecdotally that patients tolerate opioid reduction better when cannabis is available Anecdote. Controlled evidence is absent.
What doesn't work or has weak evidence
Cannabis as a stand-alone treatment for opioid use disorder. There is no high-quality evidence that cannabis treats opioid addiction. Some cohort studies suggest cannabis use during MOUD treatment is associated with worse treatment retention or more illicit opioid use, though findings are inconsistent across studies Disputed[8].
The population-level overdose death claim. The widely cited Bachhuber et al. (2014) paper found that states with medical cannabis laws had approximately 25% lower opioid overdose mortality between 1999 and 2010 [4]. When Shover et al. (2019) extended the same analysis to 2017, the correlation reversed—states with medical cannabis laws had slightly higher overdose mortality [5]. This is a textbook example of an ecological correlation that did not survive extended observation Disputed.
"Cannabis is simply a safer painkiller than opioids." This conflates two separate claims. Cannabis has a much lower acute overdose death risk than opioids Strong evidence, but that is a floor-low comparison. Cannabis carries its own risks—cannabis use disorder (affecting ~10% of users and ~30% of daily users), cognitive impairment, anxiety or psychosis, and other harms—that are routinely minimized in marketing messaging.
What we don't know
- Whether THC, CBD, or specific cannabinoid ratios drive opioid-sparing effects. Most trials use whole-plant material or nabiximols; individual component contributions remain unclear.
- Whether long-term cannabis use for pain improves or worsens functional outcomes (work, mood, sleep, substance use) versus standard opioid-reduction protocols.
- Whether cannabis helps or harms retention in buprenorphine or methadone treatment. Studies show conflicting associations [8].
- Optimal dosing, route (inhaled vs. oral), frequency, and treatment duration.
- Effects in older adults, who represent a growing proportion of both chronic pain patients and opioid-dispensed populations but are rarely included in cannabis trials.
- Whether early CBD findings for opioid craving will replicate in larger trials with overdose or relapse endpoints.
- The role of cannabis use disorder risk in opioid-substitution decisions. If someone has OUD and a history of substance use, their risk of developing cannabis dependence is substantially elevated.
Comparison with standard treatments
| Condition | Standard of care | Cannabis evidence |
|---|---|---|
| Opioid use disorder (OUD) | Buprenorphine, methadone, or naltrexone Strong evidence[3][6] | Insufficient for stand-alone treatment Weak / limited |
| Chronic non-cancer pain (opioid reduction) | Multimodal: physical therapy, non-opioid analgesics (NSAIDs, acetaminophen), behavioral/psychological therapy, antidepressants | Modest opioid-sparing in observational studies Weak / limited; effect size modest |
| Acute pain | Short-course opioids, NSAIDs, acetaminophen | Limited evidence; not first-line |
| Opioid withdrawal | Buprenorphine, methadone, lofexidine, clonidine | Anecdotal reports; no controlled trials for symptom relief Anecdote |
Key difference: MOUD reduces all-cause mortality by approximately 50% in people with OUD [6]. No cannabis intervention has demonstrated comparable mortality benefit. Substituting cannabis for MOUD in someone with active opioid addiction is not supported by current evidence and carries significant overdose risk.
Risks and harms
- Cannabis use disorder (CUD). Roughly 10% of cannabis users and approximately 30% of daily users meet diagnostic criteria for CUD over time Strong evidence[9]. Trading opioid dependence for cannabis dependence is still a dependency trade-off and not clearly favorable.
- Drug interactions. THC and CBD inhibit cytochrome P450 enzymes and can substantially alter plasma levels of methadone, benzodiazepines, warfarin, and other medications Strong evidence. Clinicians should monitor for efficacy changes and toxicity if cannabis is added or removed.
- Respiratory and sedation stacking. Combining cannabis with opioids, benzodiazepines, or alcohol increases sedation and respiratory depression risk. While cannabis alone rarely causes fatal respiratory depression, the combination hazard is real.
- Mental health effects. THC can worsen anxiety and increases psychosis risk in vulnerable individuals. People with OUD and co-occurring PTSD or depression may experience symptom worsening rather than improvement Weak / limited.
- Cardiovascular events. Acute THC exposure increases heart rate and may increase myocardial infarction risk in susceptible individuals, particularly older adults and those with pre-existing cardiovascular disease Weak / limited.
- Impaired cognition. Regular cannabis use, especially in people with developing or aging brains, is associated with reductions in processing speed, attention, and working memory Weak / limited.
- Legal and employment risk. Even in legal-cannabis states, federal employees, many transportation and safety-sensitive workers, and patients on controlled-substance pain contracts face termination or legal jeopardy for cannabis use. This risk is real and should be disclosed.
- Cannabinoid hyperemesis syndrome. A small proportion of heavy users experience intractable nausea and vomiting that resolves only upon cessation Weak / limited. See Cannabis Hyperemesis Syndrome (CHS).
Bottom line
Cannabis shows weak but nonzero evidence for reducing opioid doses in some chronic pain patients. However, it is not a substitute for proven addiction treatment in people with OUD. The early population-level claim that medical cannabis laws reduce overdose deaths did not survive extended data analysis and has been reversed. If you or someone you know has opioid use disorder, the evidence-based and life-saving move is access to buprenorphine or methadone, combined with behavioral support. Cannabis might play a supporting role in pain management alongside these treatments, but not in place of them.
This article is for education only. It is not medical advice. Decisions about opioids, OUD treatment, cannabis, or any change to your medication must involve a qualified clinician who knows your full medical history.
Sources
- Peer-reviewed Whiting PF, Wolff RF, Deshpande S, et al. (2015). Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA, 313(24), 2456-2473.
- Peer-reviewed Boehnke KF, Litinas E, Clauw DJ (2016). Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain. The Journal of Pain, 17(6), 739-744.
- Government National Academies of Sciences, Engineering, and Medicine (2019). Medications for Opioid Use Disorder Save Lives.
- Peer-reviewed Bachhuber MA, Saloner B, Cunningham CO, Barry CL (2014). Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010. JAMA Internal Medicine, 174(10), 1668-1673.
- Peer-reviewed Shover CL, Davis CS, Gordon SC, Humphreys K (2019). Association between medical cannabis laws and opioid overdose mortality has reversed over time. PNAS, 116(26), 12624-12626.
- Peer-reviewed Sordo L, Barrio G, Bravo MJ, et al. (2017). Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ, 357, j1550.
- Peer-reviewed Hurd YL, Greenwald MK, Chambers RA, et al. (2019). Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial. American Journal of Psychiatry, 176(11), 911-922.
- Peer-reviewed McBrien H, Christensen E, Schuler A, et al. (2019). Cannabis use during methadone maintenance treatment for opioid use disorder: a systematic review and meta-analysis. CMAJ Open, 7(4), E665-E673.
- Peer-reviewed Hasin DS (2018). US Epidemiology of Cannabis Use and Associated Problems. Neuropsychopharmacology, 43(1), 195-212.
How this page was made
Generation history
Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.
Related
- Cannabis and Bipolar Disorder — Why cannabis use worsens bipolar outcomes despite subjective relief, and what the research...
- Cannabis and Polypharmacy Risks — How cannabis affects multiple-medication regimens, and which interactions are real.
- Cannabis Hyperemesis Syndrome (CHS) — Severe cyclic vomiting triggered by chronic heavy cannabis use; resolves on cessation.
- THC Dose and Anxiety — Low doses may reduce acute anxiety; higher doses increase it. Evidence is limited, risks a...